153 related articles for article (PubMed ID: 10235301)
1. Conversion of acetaldehyde-protein adduct epitopes from a nonreduced to a reduced phenotype by antigen processing cells.
Klassen LW; Jones BL; Sorrell MF; Tuma DJ; Thiele GM
Alcohol Clin Exp Res; 1999 Apr; 23(4):657-63. PubMed ID: 10235301
[TBL] [Abstract][Full Text] [Related]
2. [Immune response against protein epitopes modified with acetaldehyde and its clinical significance in alcoholic liver diseases].
Yokoyama H
Arukoru Kenkyuto Yakubutsu Ison; 1993 Dec; 28(6):483-96. PubMed ID: 7510476
[TBL] [Abstract][Full Text] [Related]
3. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant.
Thiele GM; Tuma DJ; Willis MS; Miller JA; McDonald TL; Sorrell MF; Klassen LW
Alcohol Clin Exp Res; 1998 Nov; 22(8):1731-9. PubMed ID: 9835288
[TBL] [Abstract][Full Text] [Related]
4. Antibodies made against a formaldehyde-protein adduct cross react with an acetaldehyde-protein adduct. Implications for the origin of antibodies in human serum which recognize acetaldehyde-protein adducts.
Pietrzak ER; Shanley BC; Kroon PA
Alcohol Alcohol; 1995 May; 30(3):373-8. PubMed ID: 7545992
[TBL] [Abstract][Full Text] [Related]
5. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption.
Viitala K; Israel Y; Blake JE; Niemelä O
Hepatology; 1997 Jun; 25(6):1418-24. PubMed ID: 9185762
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease.
Rolla R; Vay D; Mottaran E; Parodi M; Traverso N; Aricó S; Sartori M; Bellomo G; Klassen LW; Thiele GM; Tuma DJ; Albano E
Hepatology; 2000 Apr; 31(4):878-84. PubMed ID: 10733543
[TBL] [Abstract][Full Text] [Related]
7. The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. II. Epidermal Langerhans' cells and peritoneal exudate macrophages.
Morikawa Y; Furotani M; Matsuura N; Kakudo K
Cell Immunol; 1993 Nov; 152(1):200-10. PubMed ID: 8242760
[TBL] [Abstract][Full Text] [Related]
8. Protein adduct species in muscle and liver of rats following acute ethanol administration.
Patel VB; Worrall S; Emery PW; Preedy VR
Alcohol Alcohol; 2005; 40(6):485-93. PubMed ID: 16131499
[TBL] [Abstract][Full Text] [Related]
9. Detection of reduced acetaldehyde protein adducts using a unique monoclonal antibody.
Klassen LW; Tuma DJ; Sorrell MF; McDonald TL; DeVasure JM; Thiele GM
Alcohol Clin Exp Res; 1994 Feb; 18(1):164-71. PubMed ID: 8198215
[TBL] [Abstract][Full Text] [Related]
10. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay.
Xu D; Thiele GM; Kearley ML; Haugen MD; Klassen LW; Sorrell MF; Tuma DJ
Chem Res Toxicol; 1997 Sep; 10(9):978-86. PubMed ID: 9305579
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts.
Israel Y; Hurwitz E; Niemelä O; Arnon R
Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7923-7. PubMed ID: 2429322
[TBL] [Abstract][Full Text] [Related]
12. Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation.
Willis MS; Klassen LW; Tuma DJ; Sorrell MF; Thiele GM
Alcohol Clin Exp Res; 2002 Jan; 26(1):94-106. PubMed ID: 11821659
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers.
Viitala K; Makkonen K; Israel Y; Lehtimäki T; Jaakkola O; Koivula T; Blake JE; Niemelä O
Alcohol Clin Exp Res; 2000 Jul; 24(7):1103-9. PubMed ID: 10924016
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity to acetaldehyde-protein adducts.
Israel Y; MacDonald A; Niemelä O; Zamel D; Shami E; Zywulko M; Klajner F; Borgono C
Mol Pharmacol; 1992 Oct; 42(4):711-7. PubMed ID: 1435747
[TBL] [Abstract][Full Text] [Related]
15. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates.
Latvala J; Melkko J; Parkkila S; Järvi K; Makkonen K; Niemelä O
Alcohol Clin Exp Res; 2001 Nov; 25(11):1648-53. PubMed ID: 11707639
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption.
Niemelä O; Juvonen T; Parkkila S
J Clin Invest; 1991 Apr; 87(4):1367-74. PubMed ID: 1707062
[TBL] [Abstract][Full Text] [Related]
17. Ethanol induces the production of antibodies to acetaldehyde-modified epitopes in rats.
Worrall S; De Jersey J; Shanley BC; Wilce PA
Alcohol Alcohol; 1989; 24(3):217-23. PubMed ID: 2474297
[TBL] [Abstract][Full Text] [Related]
18. In vitro exposure to malondialdehyde-acetaldehyde adducted protein inhibits cell proliferation and viability.
Willis MS; Klassen LW; Tuma DJ; Sorrell MF; Thiele GM
Alcohol Clin Exp Res; 2002 Feb; 26(2):158-64. PubMed ID: 11964554
[TBL] [Abstract][Full Text] [Related]
19. Experimental studies on the relationship between immune responses and liver damage induced by ethanol after immunization with homologous acetaldehyde adducts.
Shimada S; Yamauchi M; Takamatsu M; Uetake S; Ohata M; Saito S
Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):86S-90S. PubMed ID: 12198382
[TBL] [Abstract][Full Text] [Related]
20. T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated.
Willis MS; Thiele GM; Tuma DJ; Klassen LW
Int Immunopharmacol; 2003 Oct; 3(10-11):1381-99. PubMed ID: 12946435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
